Monday, November 18, 2024
HomeTagsClinical Microbiology

Clinical Microbiology

Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus

Enanta Pharmaceuticals, Inc, a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, announced that the U.S. Food and Drug Administration...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics